SV Health Investors svhealthinvestors.com

SV Health Investors - Key People

Name Bio Twitter
Houman AshrafianBefore joining SV, Ashrafian was Vice President and Head of the Clinical Science Group at UCB Pharma. Ashrafian currently serves as Visiting Professor and Head of Experimental Therapeutics at the University of Oxford and as an Honorary Consultant Car show more…
Kate BinghamKate Bingham joined SVLS in 1991. Kate currently serves or has served on the boards of companies in the UK, US, Ireland, Sweden and Germany. She has been responsible for past investments in Alantos, Auxilium, ESBATech, Hexagen, Kinetix, KuDOS, Leuko show more…
Graham BoulnoisProfessor Graham Boulnois joined SVLS as a Venture Partner in 2001 and became a Partner in 2004. Graham is a Director of Delanex, Oxagen,Affinium and Vantia. He has responsibility for overseeing the investment in Cellzome. He was a Director at Lorant show more…
Hamish CameronDr Hamish Cameron joined SVLS in 2008 as a Venture Partner and became an Operating Partner in 2014. He has been Interim CEO at X2-Pharma, Delenex Therapeutics and TopiVert Pharma and Chief Commercial Officer at ESBATech. He is currently a Director a show more…
Mike CarterDr. Michael Carter joined SVLS in 1998 as a Venture Partner. From 1986 to 1998 Michael was on the board of Zeneca Pharmaceuticals and from 1995 - 1998 was also a board member of Salick Healthcare - a US subsidiary of Zeneca.

Prior Experien show more…
See all 16 people